Miss Vorawan Ummaritchot, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 100 Highland Ave, Suite 203, Providence, RI 02906 Phone: 401-351-7100 Fax: 401-751-6179 |
Brittany Ann Ricci, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-3420 Fax: 401-649-4091 |
Ivana Lukacova-zib, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1 Hoppin St, Suite 200, Providence, RI 02903 Phone: 401-444-8344 Fax: 401-444-4921 |
Roberto Ortiz, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 100 Highland Ave, Providence, RI 02906 Phone: 401-351-7100 Fax: 401-751-6179 |
Kenneth K Chen, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 101 Dudley St, Providence, RI 02905 Phone: 401-274-1100 |
Robert J Smith, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1 Hoppin St, Suite 200, Providence, RI 02903 Phone: 401-444-8344 Fax: 401-444-7870 |
David B Maclean, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1 Hoppin St, Suite 200, Providence, RI 02903 Phone: 401-444-8344 Fax: 401-444-7870 |
Robert J Dobrzynski Jr., M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 100 Highland Ave, 203, Providence, RI 02906 Phone: 401-351-7100 Fax: 401-751-6179 |
Dr. Joseph Ralph Tucci, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 50 Maude St, Providence, RI 02908 Phone: 401-456-5716 Fax: 401-456-6546 |
Charles B Kahn, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 49 Seekonk St, Providence, RI 02906 Phone: 401-351-7100 |
Maged Taman, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 21 Peace Street, Providence, RI 02907 Phone: 401-456-4122 |
Nadia Jamil, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-3420 Fax: 401-444-4921 |
Dominic F Corrigan, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 830 Chalkstone Ave, Providence, RI 02908 Phone: 401-273-7100 |
Dennis S Krauss, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 49 Seekonk St, Providence, RI 02906 Phone: 401-351-7100 |
News Archive
Low baseline diastolic blood pressure appears to be associated with brain atrophy in patients with arterial disease, whenever declining levels of blood pressure over time among patients who had a higher baseline BP were associated with less progression of atrophy, according to a report published Online First by JAMA Neurology, a JAMA Network publication.
BD Medical, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, today announced that the U.S. Food and Drug Administration has cleared the BD Intelliport Medication Management System, the first-of-its-kind medication management solution for manual IV bolus injections.
With the COVID-19 pandemic resulting in lockdowns in different parts of the world, from the US to many European nations, there have been intense debates on when and how we can safely reopen the economy.
Scientists from EPFL and ETHZ have developed a powerful tool for exploring and determining the inherent biological differences between individuals, which overcomes a major hurdle for personalized medicine.
EpiCept Corporation today announced that at a recent meeting with the U.S. Food and Drug Administration (FDA) the Company was provided more definitive guidance regarding the clinical development of Ceplene, the Company's lead product administered with interleukin-2 (IL-2) for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission.
› Verified 8 days ago